NOW JOIN US NOW IN REVEAL Prospective Observational Study of Patients with Polycythemia Vera in US Clinical Practices (NCT02252159) The REVEAL study is a multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients ≥18 years old) of men and women who have been diagnosed with clinically overt PV.
Patients with PV N=2000
Study start
SCREENING
START OBSERVATION
Usual Care 36 months
DATA COLLECTION
Key Inclusion Criteria
Key Exclusion Criteria
• Age ≥18 years, diagnosis of polycythemia vera (PV) • Willing and able to provide signed informed consent • Under the supervision of US physician
• • • • •
End of study
END OBSERVATION
Participation in a blinded study Life expectancy <6 months Diagnosis of MF, PPV-MF, PET-MF Diagnosis of acute myelocytic leukemia (AML) Diagnosis of Myelodysplastic Syndrome
To join us as an investigative site in REVEAL:
Incyte REVEAL Study Hotline: 1-855-REVEAL-9
RevealPVStudy.com
Protocol Number INCB-MA-PV-401 sponsored by Incyte Corporation © 2015 Incyte Corporation
Info@RevealPVStudy.com